Carregant...
A prospective trial of vaccine to prevent hepatitis B virus reactivation after hematopoietic stem cell transplantation
Hepatitis B virus (HBV) reactivation reportedly occurs frequently after hematopoietic stem cell transplantation (HSCT) in resolved HBV-infected patients. Here, 50 patients with resolved HBV infections and scheduled to undergo HSCT were enrolled; all subjects were vaccinated with three doses of hepat...
Guardat en:
| Publicat a: | Bone Marrow Transplant |
|---|---|
| Autors principals: | , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Nature Publishing Group UK
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7329632/ https://ncbi.nlm.nih.gov/pubmed/32071416 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41409-020-0833-5 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|